Request For Information: NINDS Division Translational Research – Continuous Rodent And Non-Rodent Pharmacokinetic (PK) Assessments

Classification: Medical – Laboratory Testing
Business value: $19M

Background:

The National Institute of Neurological Disorders and Stroke (NINDS) and the NIH Blueprint Neurotherapeutics Network (BPN) have established a ‘virtual pharma’ network of contract service providers and consultants with extensive industry experience to enable therapeutic (e.g., small molecule, peptide, biologic) development in the NIH research community. This network has a need to run routine pharmacokinetic studies in support of the program. Studies are mostly iv/po rodent studies but information on capabilities to run other routes of administration and other species is also of interest.

Purpose and Objectives:

The NINDS is interested in identifying commercial sources with capabilities and qualifications that could run routine rodents pharmacokinetic (PK) testing for the purposes of new therapeutics developments. Additionally, information capabilities to run dog PK and other routes of administration is also sought.

Sample Designs for Consideration:
1. Rat Pharmacokinetic with or without brain level determination

2. Rodent Brain Pharmacokinetics Analysis

3. Rodent Plasma Sample Pharmacokinetic Analysis

4. Mouse Pharmacokinetic with or without brain level determination

5. Dog Pharmacokinetic determination

Information Sought:
One (1) copy of the response is required and must be in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2” x 11” paper size, with 1” top, bottom, left and right margins, and with single or double spacing.

The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required.

The response is limited to twenty (20) page limit. The 20-page limit does not include the cover page, executive summary, or references, if requested.

All responses to this notice must be submitted electronically to the Contract Specialist.

The response must be submitted to Sneha Singh, Contract Specialist, at e-mail address sneha.singh@nih.gov

Note:

• FindmyCustomer offers strategic partnership support for Pharma business through its company “Amedra Healthcare.” For business inquiries, please contact us at director@amedra.in
• To receive notification of such exclusive high value pharma leads at no cost, share this lead on your social media and tag us.